For example, Cheng et al. found that hsa-miR-16-5p inhibited invasion and migration of HCC by targeting IGF1R [30]; Li et al. showed that miR-140-3p enhanced the sensitivity of HCC cells to sorafenib by directly suppressing PXR [31]. This evidence concerns the gene NR1I2 and hepatocellular carcinoma.